.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Colorcon
UBS
Merck
Chinese Patent Office
Baxter
AstraZeneca
QuintilesIMS
Cantor Fitzgerald

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206815

« Back to Dashboard

NDA 206815 describes SODIUM POLYSTYRENE SULFONATE, which is a drug marketed by Ailex Pharms Llc, Belcher Pharms Llc, Citrusphrma, Cmp Pharma Inc, Eci Pharms Llc, Epic Pharma Llc, Nuvo Pharm Inc, Wockhardt, Morton Grove, Paddock Llc, Roxane, and West-ward Pharms Int, and is included in twelve NDAs. It is available from eleven suppliers. Additional details are available on the SODIUM POLYSTYRENE SULFONATE profile page.

The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.

Summary for 206815

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 206815

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 206815 ANDA Trigen Laboratories, LLC 13811-656 13811-656-53 453.6 g in 1 JAR (13811-656-53)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORAL, RECTALStrength454GM/BOT
Approval Date:Feb 18, 2016TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
McKesson
Moodys
Dow
Teva
Baxter
Queensland Health
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot